Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Aug 2, 2017

30870_dirs_2017-08-02_4e2eddd7-b067-491e-b563-c892e748775e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-08-01

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-01 Common Stock S 100 $13.55 Disposed 84785 Direct
2017-08-01 Common Stock S 100 $13.6 Disposed 84685 Direct
2017-08-01 Common Stock S 500 $13.65 Disposed 84185 Direct
2017-08-01 Common Stock S 100 $13.675 Disposed 84085 Direct
2017-08-01 Common Stock S 900 $13.7 Disposed 83185 Direct
2017-08-01 Common Stock S 300 $13.75 Disposed 82885 Direct
2017-08-01 Common Stock S 1123 $13.8 Disposed 81762 Direct
2017-08-01 Common Stock S 100 $13.825 Disposed 81662 Direct
2017-08-01 Common Stock S 695 $13.85 Disposed 80967 Direct
2017-08-01 Common Stock S 500 $13.875 Disposed 80467 Direct
2017-08-01 Common Stock S 405 $13.9 Disposed 80062 Direct
2017-08-01 Common Stock S 177 $14.2 Disposed 79885 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.